Research ExplorerScientific StaffWalter Fiedler Publications

Prof.Dr. ID: 50717

Walter Fiedler

graph of relations
Affiliations
51 - 100 out of 195Page size: 50

Publications

  1. 2021

  2. Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy

    Wei, A. H., Panayiotidis, P., Montesinos, P., Laribi, K., Ivanov, V., Kim, I., Novak, J., Stevens, D. A., Fiedler, W., Pagoni, M., Bergeron, J., Ting, S. B., Hou, J-Z., Anagnostopoulos, A., McDonald, A., Murthy, V., Yamauchi, T., Wang, J., Chyla, B., Sun, Y., Jiang, Q., Mendes, W., Hayslip, J. & DiNardo, C. D., 26.10.2021, In: BLOOD CANCER J. 11, 10, p. 171

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  3. 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (141/150)

    Wei, A. H., Panayiotidis, P., Montesinos, P., Laribi, K., Ivanov, V., Kim, I., Novak, J., Stevens, D. A., Fiedler, W., Pagoni, M., Bergeron, J., Ting, S. B., Hou, J-Z., Anagnostopoulos, A., McDonald, A., Murthy, V., Yamauchi, T., Wang, J., Chyla, B., Sun, Y., Jiang, Q., Mendes, W., Hayslip, J. & DiNardo, C. D., 01.10.2021, In: BLOOD CANCER J. 11, 10, p. 163

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Mebendazole Mediates Proteasomal Degradation of GLI Transcription Factors in Acute Myeloid Leukemia

    Freisleben, F., Modemann, F., Muschhammer, J., Stamm, H., Brauneck, F., Krispien, A., Bokemeyer, C., Kirschner, K. N., Wellbrock, J. & Fiedler, W., 01.10.2021, In: INT J MOL SCI. 22, 19, p. 10670

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Zytopenie-Mamgement akute myeloische Leukämie

    Bullinger, L., Fiedler, W., Rieger, C. & Schliemann, C., 09.2021, Georg Thieme Verlag.

    Research output: Book/anthology › Special Journal issue › Research

  6. Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial

    Döhner, H., Symeonidis, A., Deeren, D., Demeter, J., Sanz, M. A., Anagnostopoulos, A., Esteve, J., Fiedler, W., Porkka, K., Kim, H-J., Lee, J-H., Usuki, K., D'Ardia, S., Won Jung, C., Salamero, O., Horst, H-A., Recher, C., Rousselot, P., Sandhu, I., Theunissen, K., Thol, F., Döhner, K., Teleanu, V., DeAngelo, D. J., Naoe, T., Sekeres, M. A., Belsack, V., Ge, M., Taube, T. & Ottmann, O. G., 08.2021, In: HEMASPHERE. 5, 8, p. e617

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19

    Woo, M. S., Haag, F., Nierhaus, A., Jarczak, D., Roedl, K., Mayer, C., Brehm, T. T., van der Meirschen, M., Hennigs, A., Christopeit, M., Fiedler, W., Karagiannis, P., Burdelski, C., Schultze, A., Huber, S., Addo, M. M., Schmiedel, S., Friese, M. A., Kluge, S. & Schulze Zur Wiesch, J., 23.07.2021, In: ISCIENCE. 24, 7, p. 102752

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

    Heuser, M., Smith, B. D., Fiedler, W., Sekeres, M. A., Montesinos, P., Leber, B., Merchant, A., Papayannidis, C., Pérez-Simón, J. A., Hoang, C. J., O'Brien, T., Ma, W. W., Zeremski, M., O'Connell, A., Chan, G. & Cortes, J. E., 07.2021, In: ANN HEMATOL. 100, 7, p. 1917-1918 2 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  9. Increased frequency of TIGIT+CD73-CD8+ T cells with a TOX+ TCF-1low profile in patients with newly diagnosed and relapsed AML

    Brauneck, F., Haag, F., Woost, R., Wildner, N., Tolosa, E., Rissiek, A., Vohwinkel, G., Wellbrock, J., Bokemeyer, C., Schulze Zur Wiesch, J., Ackermann, C. & Fiedler, W., 21.06.2021, In: ONCOIMMUNOLOGY. 10, 1, p. 1930391

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin

    Schmalbrock, L. K., Dolnik, A., Cocciardi, S., Sträng, E., Theis, F., Jahn, N., Panina, E., Blätte, T. J., Herzig, J. K., Skambraks, S., Rücker, F. G., Gaidzik, V. I., Paschka, P., Fiedler, W., Salih, H. R., Wulf, G. G., Schroeder, T., Lübbert, M., Schlenk, R. F., Thol, F., Heuser, M., Larson, R. A., Ganser, A., Stunnenberg, H. G., Minucci, S., Stone, R. M., Bloomfield, C. D., Döhner, H., Döhner, K. & Bullinger, L., 03.06.2021, In: BLOOD. 137, 22, p. 3093-3104 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020

    Brehm, T. T., Heyer, A., Roedl, K., Jarczak, D., Nierhaus, A., Nentwich, M. F., van der Meirschen, M., Schultze, A., Christner, M., Fiedler, W., Kröger, N., Huber, T. B., Klose, H., Sterneck, M., Jordan, S., Kreuels, B., Schmiedel, S., Addo, M. M., Huber, S., Lohse, A. W., Kluge, S. & Schulze Zur Wiesch, J., 24.05.2021, In: J CLIN MED. 10, 11, 2274.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations

    Heuser, M., Heida, B., Büttner, K., Wienecke, C. P., Teich, K., Funke, C., Brandes, M., Klement, P., Liebich, A., Wichmann, M., Neziri, B., Chaturvedi, A., Kloos, A., Mintzas, K., Gaidzik, V. I., Paschka, P., Bullinger, L., Fiedler, W., Heim, A., Puppe, W., Krauter, J., Döhner, K., Döhner, H., Ganser, A., Stadler, M., Hambach, L., Gabdoulline, R. & Thol, F., 11.05.2021, In: BLOOD ADV. 5, 9, p. 2294-2304 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

    Heuser, M., Smith, B. D., Fiedler, W., Sekeres, M. A., Montesinos, P., Leber, B., Merchant, A., Papayannidis, C., Pérez-Simón, J. A., Hoang, C. J., O'Brien, T., Ma, W. W., Zeremski, M., O'Connell, A., Chan, G. & Cortes, J. E., 05.2021, In: ANN HEMATOL. 100, 5, p. 1181-1194 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza

    Brehm, T. T., van der Meirschen, M., Hennigs, A., Roedl, K., Jarczak, D., Wichmann, D., Frings, D., Nierhaus, A., Oqueka, T., Fiedler, W., Christopeit, M., Kraef, C., Schultze, A., Lütgehetmann, M., Addo, M. M., Schmiedel, S., Kluge, S. & Schulze Zur Wiesch, J., 11.03.2021, In: SCI REP-UK. 11, 1, 5803.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Newly diagnosed isolated myeloid sarcoma-paired NGS panel analysis of extramedullary tumor and bone marrow

    Engel, N. W., Reinert, J., Borchert, N. M., Panagiota, V., Gabdoulline, R., Thol, F., Heuser, M. & Fiedler, W., 02.2021, In: ANN HEMATOL. 100, 2, p. 499-503 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high-dose cytarabine and mitoxantrone

    Karagiannis, P., Alsdorf, W., Tallarek, A-C., Blohm, M. E., Oelrich, J., Waizenegger, J. S., Wolschke, C., Hecher, K., Singer, D., Bokemeyer, C. & Fiedler, W., 01.2021, In: BRIT J HAEMATOL. 192, 2, p. e60-e63

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  17. High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells

    Teo Hansen Selnø, A., Schlichtner, S., Yasinska, I. M., Sakhnevych, S. S., Fiedler, W., Wellbrock, J., Berger, S. M., Klenova, E., Gibbs, B. F., Fasler-Kan, E. & Sumbayev, V. V., 2021, In: FRONT IMMUNOL. 12, 675731.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. 2020

  19. Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial

    Kapp-Schwoerer, S., Weber, D., Corbacioglu, A., Gaidzik, V. I., Paschka, P., Krönke, J., Theis, F., Rücker, F. G., Teleanu, M-V., Panina, E., Jahn, N., Herzig, J., Kubanek, L., Schrade, A., Göhring, G., Fiedler, W., Kindler, T., Schroeder, T., Mayer, K. T., Lübbert, M., Wattad, M., Götze, K. S., Horst, H. A., Koller, E., Wulf, G., Schleicher, J., Bentz, M., Krauter, J., Bullinger, L., Krzykalla, J., Benner, A., Schlenk, R. F., Thol, F., Heuser, M., Ganser, A., Döhner, H. & Döhner, K., 24.12.2020, In: BLOOD. 136, 26, p. 3041-3050 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients

    Ghandili, S., Pfefferle, S., Roedl, K., Sonnemann, P., Karagiannis, P., Boenisch, O., Kluge, S., Schmiedel, S., Ittrich, H., Rohde, H., Lütgehetmann, M., Weisel, K., Bokemeyer, C., Wichmann, D., Fiedler, W., Jarczak, D. & Modemann, F., 08.12.2020, In: Blood Adv. 4, 23, p. 5936-5941 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells

    Selnø, A. T. H., Schlichtner, S., Yasinska, I. M., Sakhnevych, S. S., Fiedler, W., Wellbrock, J., Klenova, E., Pavlova, L., Gibbs, B. F., Degen, M., Schnyder, I., Aliu, N., Berger, S. M., Fasler-Kan, E. & Sumbayev, V. V., 08.12.2020, In: AGING-US. 12, 23, p. 23478-23496 19 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity

    Yasinska, I. M., Meyer, N. H., Schlichtner, S., Hussain, R., Siligardi, G., Casely-Hayford, M., Fiedler, W., Wellbrock, J., Desmet, C., Calzolai, L., Varani, L., Berger, S. M., Raap, U., Gibbs, B. F., Fasler-Kan, E. & Sumbayev, V. V., 20.11.2020, In: FRONT IMMUNOL. 11, p. 580557

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results

    Heuser, M., Palmisiano, N., Mantzaris, I., Mims, A., DiNardo, C., Silverman, L. R., Wang, E. S., Fiedler, W., Baldus, C., Schwind, S., Pardee, T., Perl, A. E., Cai, C., Kaulfuss, S., Lagkadinou, E., Rentzsch, C., Wagner, M., Wilkinson, G., Wu, B., Jeffers, M., Genvresse, I. & Krämer, A., 11.2020, In: LEUKEMIA. 34, 11, p. 2903-2913 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia

    Fiedler, W., Chromik, J., Amberg, S., Kebenko, M., Thol, F., Schlipfenbacher, V., Christine Wilke, A., Modemann, F., Janning, M., Serve, H., Ganser, A., Bokemeyer, C., Theile, S., Deppermann, U., Kranich, A. L. & Heuser, M., 08.2020, In: BRIT J HAEMATOL. 190, 3, p. e169-e173

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  25. Downregulation of GLI3 Expression Mediates Chemotherapy Resistance in Acute Myeloid Leukemia

    Freisleben, F., Behrmann, L., Thaden, V., Muschhammer, J., Bokemeyer, C., Fiedler, W. & Wellbrock, J., 18.07.2020, In: INT J MOL SCI. 21, 14

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy

    Cortes, J. E., Heidel, F. H., Fiedler, W., Smith, B. D., Robak, T., Montesinos, P., Candoni, A., Leber, B., Sekeres, M. A., Pollyea, D. A., Ferdinand, R., Ma, W. W., O'Brien, T., O'Connell, A., Chan, G. & Heuser, M., 14.07.2020, In: J HEMATOL ONCOL. 13, 1, p. 92

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis

    Karagiannis, P., Sänger, L., Alsdorf, W., Weisel, K., Fiedler, W., Kluge, S., Wichmann, D., Bokemeyer, C. & Fuhrmann, V., 24.06.2020, In: CANCERS. 12, 6, 1678.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: phase 3 randomized placebo-controlled trial

    Wei, A. H., Montesinos, P., Ivanov, V., DiNardo, C. D., Novak, J., Laribi, K., Kim, I., Stevens, D., Fiedler, W., Pagoni, M., Samoilova, O., Hu, Y., Anagnostopoulos, A., Bergeron, J., Hou, J-Z., Murthy, V., Yamauchi, T., McDonald, A. B., Chyla, B., Gopalakrishnan, S., Jiang, Q., Mendes, W. L., Hayslip, J. & Panayiotidis, P., 11.06.2020, In: BLOOD. 135, 24, p. 2137-2145 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg: Report of the University Cancer Center Hamburg

    Weisel, K. C., Morgner-Miehlke, A., Petersen, C., Fiedler, W., Block, A., Schafhausen, P., Knobloch, J. K. & Bokemeyer, C., 07.05.2020, In: ONCOL RES TREAT. 43, 6, p. 307-313 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  30. Successful Treatment of Delayed Methotrexate Clearance using Glucarpidase Dosed on Ideal Body Weight in Obese Patients

    Krüger, C., Engel, N., Reinert, J., Alsdorf, W., Fiedler, W., Dierlamm, J., Bokemeyer, C. & Langebrake, C., 05.2020, In: PHARMACOTHERAPY. 40, 5, p. 479-483 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. The bone marrow stromal niche: a therapeutic target of hematological myeloid malignancies

    Behrmann, L., Wellbrock, J. & Fiedler, W., 05.2020, In: EXPERT OPIN THER TAR. 24, 5, p. 451-462 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  32. Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial

    Cicconi, L., Platzbecker, U., Avvisati, G., Paoloni, F., Thiede, C., Vignetti, M., Fazi, P., Ferrara, F., Divona, M., Albano, F., Efficace, F., Sborgia, M., Di Bona, E., Breccia, M., Borlenghi, E., Cairoli, R., Rambaldi, A., Melillo, L., La Nasa, G., Fiedler, W., Brossart, P., Hertenstein, B., Salih, H. R., Annibali, O., Wattad, M., Lubbert, M., Brandts, C. H., Hanel, M., Rollig, C., Schmitz, N., Link, H., Frairia, C., Fozza, C., Maria D'Arco, A., Di Renzo, N., Cortelezzi, A., Fabbiano, F., Dohner, K., Ganser, A., Dohner, H., Amadori, S., Mandelli, F., Voso, M. T., Ehninger, G., Schlenk, R. F. & Lo-Coco, F., 03.2020, In: LEUKEMIA. 34, 3, p. 914-918 5 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  33. Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study

    Schlenk, R. F., Paschka, P., Krzykalla, J., Weber, D., Kapp-Schwoerer, S., Gaidzik, V. I., Leis, C., Fiedler, W., Kindler, T., Schroeder, T., Mayer, K., Lübbert, M., Wattad, M., Götze, K., Horst, H. A., Koller, E., Wulf, G., Schleicher, J., Bentz, M., Greil, R., Hertenstein, B., Krauter, J., Martens, U., Nachbaur, D., Abu Samra, M., Girschikofsky, M., Basara, N., Benner, A., Thol, F., Heuser, M., Ganser, A., Döhner, K. & Döhner, H., 20.02.2020, In: J CLIN ONCOL. 38, 6, p. 623-632 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma

    Oliveira-Ferrer, L., Milde-Langosch, K., Eylmann, K., Rossberg, M., Müller, V., Schmalfeldt, B., Witzel, I., Wellbrock, J. & Fiedler, W., 17.01.2020, In: INT J MOL SCI. 21, 2

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. 2019

  36. Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group

    Rücker, F. G., Agrawal, M., Corbacioglu, A., Weber, D., Kapp-Schwoerer, S., Gaidzik, V. I., Jahn, N., Schroeder, T., Wattad, M., Lübbert, M., Koller, E., Kindler, T., Götze, K., Ringhoffer, M., Westermann, J., Fiedler, W., Horst, H. A., Greil, R., Schroers, R., Mayer, K., Heinicke, T., Krauter, J., Schlenk, R. F., Thol, F., Heuser, M., Ganser, A., Bullinger, L., Paschka, P., Döhner, H. & Döhner, K., 07.11.2019, In: BLOOD. 134, 19, p. 1608-1618 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. The Actin Binding Protein Plastin-3 Is Involved in the Pathogenesis of Acute Myeloid Leukemia

    Velthaus, A., Cornils, K., Hennigs, J. K., Grüb, S., Stamm, H., Wicklein, D., Bokemeyer, C., Heuser, M., Windhorst, S., Fiedler, W. & Wellbrock, J., 26.10.2019, In: CANCERS. 11, 11

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. AML: Klinische Bedeutung von Spleißvarianten und Spleiß-assoziierten Genmutationen

    Janning, M. & Fiedler, W., 24.06.2019, In: Journal Onkologie - Zeitschrift für onkologische Fortbildung. 2019, 6, p. 42-45

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  39. Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study

    Wei, A. H., Strickland, S. A., Hou, J-Z., Fiedler, W., Lin, T. L., Walter, R. B., Enjeti, A., Tiong, I. S., Savona, M., Lee, S., Chyla, B., Popovic, R., Salem, A. H., Agarwal, S., Xu, T., Fakouhi, K. M., Humerickhouse, R., Hong, W-J., Hayslip, J. & Roboz, G. J., 20.05.2019, In: J CLIN ONCOL. 37, 15, p. 1277-1284 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia

    Döhner, H., Müller-Tidow, C., Lübbert, M., Fiedler, W., Krämer, A., Westermann, J., Bug, G., Schlenk, R. F., Krug, U., Goeldner, R-G., Hilbert, J., Taube, T. & Ottmann, O. G., 05.2019, In: BRIT J HAEMATOL. 185, 3, p. 583-587 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial

    Bixby, D., Noppeney, R., Lin, T. L., Cortes, J., Krauter, J., Yee, K., Medeiros, B. C., Krämer, A., Assouline, S., Fiedler, W., Dimier, N., Simmons, B. P., Riehl, T. & Colburn, D., 05.2019, In: BRIT J HAEMATOL. 185, 3, p. 595-598 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Midostaurin added to chemotherapy and continued single agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

    Schlenk, R. F., Weber, D., Fiedler, W., Salih, H. R., Wulf, G., Salwender, H., Schroeder, T., Kindler, T., Lübbert, M., Wolf, D., Westermann, J., Kraemer, D., Götze, K. S., Horst, H-A., Krauter, J., Girschikofsky, M., Ringhoffer, M., Südhoff, T., Held, G., Derigs, H-G., Schroers, R., Greil, R., Grießhammer, M., Lange, E., Burchardt, A., Martens, U., Hertenstein, B., Marretta, L., Heuser, M., Thol, F., Gaidzik, V. I., Herr, W., Krzykalla, J., Benner, A., Döhner, K., Ganser, A., Paschka, P. & Döhner, H., 21.02.2019, In: BLOOD. 133, 8, p. 840-851 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Continuous high dosing of lenalidomide in relapsed, refractory or older newly diagnosed acute myeloid leukemia patients not suitable for other treatment options - results from a phase I study

    Hütter-Krönke, M. L., Fiedler, W., Kündgen, A., Krauter, J., von Lilienfeld-Toal, M., Döhner, H. & Schlenk, R., 02.2019, In: HAEMATOLOGICA. 104, 2, p. E63-E64

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  44. Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

    Cortes, J. E., Heidel, F. H., Hellmann, A., Fiedler, W., Smith, B. D., Robak, T., Montesinos, P., Pollyea, D. A., DesJardins, P., Ottmann, O., Ma, W. W., Shaik, M. N., Laird, A. D., Zeremski, M., O'Connell, A., Chan, G. & Heuser, M., 02.2019, In: LEUKEMIA. 33, 2, p. 379-389 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. 3D in vitro system for measuring treatment responses to immunotherapy in CRC patients

    Sturmheit, T., Stamm, H., Sutus Temovski, T., Konczalla, L., Brauneck, F., Stange, I., Köllmann, S., Li, J., Perez, D., thastrup, J., Wellbrock, J., Fiedler, W., Kupper, J. & Block, A., 2019, In: J CLIN ONCOL.

    Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

  46. Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer

    Stamm, H., Oliveira-Ferrer, L., Grossjohann, E-M., Muschhammer, J., Thaden, V., Brauneck, F., Kischel, R., Müller, V., Bokemeyer, C., Fiedler, W. & Wellbrock, J., 2019, In: ONCOIMMUNOLOGY. 8, 12, p. e1674605

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. 2018

  48. Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer

    Stamm, H., Wellbrock, J. & Fiedler, W., 12.2018, In: MAMM GENOME. 29, 11-12, p. 694-702 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  49. Acute Myeloid Leukemia and the Bone Marrow Niche-Take a Closer Look

    Behrmann, L., Wellbrock, J. & Fiedler, W., 18.11.2018, In: FRONT ONCOL. 8, p. 444

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  50. Cortisol facilitates the immune escape of human acute myeloid leukemia cells by inducing latrophilin 1 expression

    Sakhnevych, S. S., Yasinska, I. M., Bratt, A. M., Benlaouer, O., Gonçalves Silva, I., Hussain, R., Siligardi, G., Fiedler, W., Wellbrock, J., Gibbs, B. F., Ushkaryov, Y. A. & Sumbayev, V. V., 11.2018, In: CELL MOL IMMUNOL. 15, 11, p. 994-997 4 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  51. Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML

    Thol, F., Gabdoulline, R., Liebich, A., Klement, P., Schiller, J., Kandziora, C., Hambach, L., Stadler, M., Koenecke, C., Flintrop, M., Pankratz, M., Wichmann, M., Neziri, B., Büttner, K., Heida, B., Klesse, S., Chaturvedi, A., Kloos, A., Göhring, G., Schlegelberger, B., Gaidzik, V. I., Bullinger, L., Fiedler, W., Heim, A., Hamwi, I., Eder, M., Krauter, J., Schlenk, R. F., Paschka, P., Döhner, K., Döhner, H., Ganser, A. & Heuser, M., 18.10.2018, In: BLOOD. 132, 16, p. 1703-1713 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)

    Krauter, J., Fiedler, W., Schlenk, R. F., Paschka, P., Thol, F., Lübbert, M., Wattad, M., Verbeek, M., Könecke, C., Neuhaus, B., Papkalla, A., Kebenko, M., Janning, M., Döhner, K., Gaidzik, V. I., Becker, H., Greil, C., Reimer, P., Götze, K. S., Döhner, H., Ganser, A. & Heuser, M., 18.10.2018, In: BRIT J HAEMATOL. 183, 2, p. 235-241 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option

    Stamm, H., Klingler, F., Grossjohann, E-M., Muschhammer, J., Vettorazzi, E., Heuser, M., Mock, U., Thol, F., Vohwinkel, G., Latuske, E., Bokemeyer, C., Kischel, R., Dos Santos, C., Stienen, S., Friedrich, M., Lutteropp, M., Nagorsen, D., Wellbrock, J. & Fiedler, W., 09.2018, In: ONCOGENE. 37, 39, p. 5269-5280 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial

    Paschka, P., Schlenk, R. F., Weber, D., Benner, A., Bullinger, L., Heuser, M., Gaidzik, V. I., Thol, F., Agrawal, M., Teleanu, V., Lübbert, M., Fiedler, W., Radsak, M., Krauter, J., Horst, H-A., Greil, R., Mayer, K., Kündgen, A., Martens, U., Heil, G., Salih, H. R., Hertenstein, B., Schwänen, C., Wulf, G., Lange, E., Pfreundschuh, M., Ringhoffer, M., Girschikofsky, M., Heinicke, T., Kraemer, D., Göhring, G., Ganser, A., Döhner, K. & Döhner, H., 09.07.2018, In: LEUKEMIA. 32, 7, p. 1621-1630 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 Next